Bleeding Prophylaxis in Bleeding Disorder Patients Undergoing GI Endoscopy

Publication Date: March 16, 2020

Key Points

Key Points

  • Low risk procedures like gastroscopy or colonoscopy without polypectomy have a bleeding risk between 0 and 0.02%.
  • In general, a number of variables increases the risk of bleeding, independent of an underlying bleeding disorder, including older age, male gender, polypectomy >7 mm, and colonoscopy performed by a low-volume endoscopist. The continued development of endoscopes and equipment is likely to reduce the bleeding risk further.
  • Three recent studies have provided detailed information on best prophylaxis practice for patients with bleeding disorders.
    • Infusing to a higher target of 80–100% and using concurrent tranexamic acid pre-procedure should be incorporated in any recommendations as well as infusing for 7–10 days if a high-risk procedure.

Treatment

...eatment...

...eeding Disorder Patients

...e pre-treatment with antifibrinolytic t...


...or Moderate or Severe Hemophilia or Severe...

...g the prophylactic factor dose to the day of the...


...the Non-inhibitor Hemophilia a Patient on...

...se infusing with FVIII to goal 80–100...


...Inhibitor Hemophilia a Patient on Emicizumab...

...e-procedure 90–120 mcg/kg and repeat the same...


...DDAVP Responsive Type 1 VWD, Low VWF or M...

...IN or IV DDAVP 60–90 min pre-procedure and co...


...c Variceal Ligation or Hemorrhoidectomy...

...dose and continue to infuse daily × 7 days.6731...


...atelet Function Disorders...

...IN/IV DDAVP 60–90 min pre-procedure and re...


...or Severe Platelet Function Disorders (Glanzmann T...

...e-administer rVIIa 90–120 mcg/kg then q2...


...rican Society of Gastrointestinal Endoscopy C...

...edures Diagnostic endoscopy (EGD,...

...rocedures Polypectomy Biliary or p...